30.04.2015 • News

BASF Trials MDI Precursor Production at Chongqing

BASF has begun trial operations at its 400,000 t/y mononitrobenzene plant at Chongqing, in western China. The new facility will feed the group's integrated MDI complex at the same location. Investment costs for the entire project are pegged at €860 million.

In addition to mononitrobenzene, the site will produce 300,000 t/y of aniline, 400,000 t/y of crude MDI and will also have an MDI splitter with a capacity of 400,000 t/y.

Located in the Chongqing Changshou Chemical Industrial Park, the complex, initially planned to go on stream in 2010, took three and a half years to be approved by Chinese authorities. A planned start-up in 2014 was delayed further by BASF's differences with officials over an increase in gas prices.

MDI is an important component for polyurethanes. BASF is building a new Polyurethane Solutions Systems House at Chongqing.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read